Although a cure is likely still a ways off, continuing to pursue long-acting injectable treatments and PrEP is key to reducing cases of HIV.
Antonio Urbina, MD
Advertisement
Medical Director for the Mount Sinai Institute for Advanced Medicine 7th Avenue clinic in New York City
Articles by Antonio Urbina, MD
Lenacapavir and cabotegravir are among the most important advancements in HIV prevention and treatment within the past 10 years.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
As Employers Pull Back on GLP-1s, Andel and Novo Offer a Workaround
2
Enlicitide LDL-C Lowering Holds Across Risk Levels Up to 2 Years
3
FDA Approves First Plasmid DNA-Based Immunotherapy for Adults With RRP
4
HS Comorbidities: Navigating Metabolic, Bowel, Cardiovascular, and Mental Health Risks
5